ArticleBMC microbiology2026
Partial purification and environmental application of CTX-type ESBL beta-lactamases from wastewater-derived E. coli isolates.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundExtended-spectrum beta-lactamases (ESBLs) of Escherichia coli give rise to resistance to broad-spectrum beta-lactam antibiotics, making treatment difficult clinically and complicating environmental management. Understanding hospital effluent as a reservoir and dissemination route for these resistant enzymes is therefore very vital.
methodsThe crude beta-lactamase enzyme extracts were partially purified by ammonium sulfate precipitation and Sephadex G-100 gel filtration chromatography, enzyme activity was assessed for observed degradation of ceftriaxone by UV spectrophotometry. Protein content was quantified by the Lowry method, and enzyme purity analyzed by SDS-PAGE. The ability of the partially purified enzymes to degrade ceftriaxone in hospital wastewater was also assessed.
resultsCrude enzyme extracts showed appreciable ceftriaxone degradation activity. Partial purification enhanced the specific activity of the enzyme while significantly reducing contaminating proteins. SDS-PAGE indicated a reduction in protein bands after purification. Partially purified enzymes showed remarkable ceftriaxone degradation in buffer and remained active, albeit to a lesser degree, in hospital wastewater.
conclusionThis study demonstrates the partial purification and characterization of CTX-type ESBL beta-lactamases from E. coli isolates obtained from wastewater. Partially purified enzymes remain active and have potential for application in reducing -beta-lactam antibiotics in hospital wastewater, thus proposing an environmental approach for curbing antibiotic resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.